Penza oncology dispensary purchases new equipment for stomach and intestines cancer detection
Penza, 12 December 2017. PenzaNews. The Penza regional oncology dispensary purchased new Japanese equipment worth 5 million roubles for stomach and intestines cancer detection.
In June-August 2017, the automatic analyser for detection of occult blood in person's biological material was tested at the premises of the oncology dispensary. Due to its high efficiency, it was decided to purchase the equipment.
During testing, more than 600 people were diagnosed and several stomach and intestine cancers were identified. To date, all these patients have received appropriate treatment.
The equipment is able to carry out about 300 examinations per day.
It allows carrying out immunoassay examinations. It is planned that about 140,000 residents of the Penza region should be examined with its help annually.
Starting 2018, this type of diagnosis will be mandatory in the framework of prophylactic medical examination for individuals over the age of 50.
Prior to the application of the new equipment, specialists conducted the benzidine test that did not allow detecting pathology in early stages. Its sensitivity was about 50-60% while that of the Japanese equipment reaches 98%.
As it was explained by the physician of the clinical pathology department of the regional oncology dispensary Yulia Zemlyanova, screening, which is carried out with the help of the purchased analyser, is the simplest, fastest and most efficient way of detecting a pathology.
"As a result of the tests, a physician shall prescribe further examination to clarify the diagnosis", the press service of the regional Ministry of Health quotes Yulia Zemlyanova.